Background: The manufacturers' criteria for a positive human immunodef
iciency virus type 1 (HIV 1) Western blot (WB) test were recently revi
sed to require reactivity to only two of the following bands: p24, gp4
1, and gp120/160. In a recent report, low-risk blood donors were ident
ified in whom nonspecific reactivity to multiple env antigens in WB te
sting resulted in apparently false-positive WBs by these criteria. The
present study was conducted to verify the existence of false-positive
WBs among noninfected donors and to assess the extent of this problem
. Study Design and Methods: Four donors classified as WB-positive on t
he basis of env-only (3 cases) or p24/env-only (1 case) patterns were
investigated. Index and/or follow-up specimens were tested by polymera
se chain reaction (PCR), by overlapping recombinant env antigens and s
ynthetic peptides in enzyme immunoassays, and by deglycosylated and de
natured antigen WBs. WB records from American Red Cross blood centers
were reviewed to determine the frequency of env-only and p24/env-only
patterns, relative to all positive WBs, from 1988 through 1993. Result
s: The four index-case donors denied risk and had stable WB reactivity
during follow-up. HIV PCR was negative in all. Env reactivity was res
tricted to nonglycosylated gp41 epitopes; no gp120-specific reactivity
was detected. For three of the four donors, env reactivity was mapped
to a 20-amino acid N-terminal epitope of gp41. The rate of detecting
WBs with these false-positive patterns increased from 0.6 percent of a
ll positive WBs from 1988 to 1990 (4/776) to 8 percent in 1991 and 199
2 (52/683), and then it declined to 6 percent in 1992 and 1993 (47/783
). Env-only patterns predominated in 1991 and 1992, whereas p24/env-on
ly patterns were more frequent following implementation of combined an
ti-HIV-1/HIV type 2 enzyme immunoassays in 1992. Conclusion: Low-risk
blood donors can have false-positive results on WB tests. Increased de
tection of env-only and p24/env-only WBs appears related to the enhanc
ed sensitivity of newer enzyme immunoassays to gp41 and p24 antibodies
. Donors with these patterns should undergo follow-up testing to docum
ent the presence or absence of HIV infection.